Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 4, 2003, Pages 278-283

  De Smet, H R ^a   Menadue, M F ^a   Oliver, J R ^a   Phillips, Paddy A ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Angiotensin II; Cardiac hypertrophy; Endothelin 1

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; BMS 193884; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT;

EID: 0037393513     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03831.x     Document Type: Article

References (34)

1. Quinones MA, Greenberg BH, Kopelen HA et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: Significance of left ventricular hypertrophy. J. Am. Coll. Cardiol. 2000; 35: 1237-44.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med. 1990; 322: 1561-6.
3. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-6.
4. Ito H, Hirata Y, Adachi S et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 1993; 92: 398-403.
5. Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996; 28: 635-40.
6. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ. Res. 1993; 73: 413-23.
7. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotype modulation and remodeling in vivo in rats. Hypertension 1995; 25: 1252-9.
8. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Am. J. Hypertens. 1992; 5: 276-80.
9. Hocher B, George I, Rebstock J et al. Endothelin system-dependent cardiac remodeling in renovascular hypertension. Hypertension 1999; 33: 816-22.
10. A receptor blockade in a transgenic, angiotensin II-dependent, rat model. Hypertension 2000; 35: 992-7.
11. 2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1. Am. J. Physiol. 1996; 270: H857-68.
12. Shubeita HE, McDonough PM, Harris AN et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J. Biol. Chem. 1990; 265: 20 555-62.
13. B receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes. J. Cardiovasc. Pharmacol. 1997; 29: 350-9.
14. Neyses L, Nouskas J, Vetter H. Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1. Biochem. Biophys. Res. Commun. 1991; 181: 22-7.
15. Noll G, Wenzel RR, Luscher TF. Endothelin and endothelin antagonists. Potential role in cardiovascular and renal disease. Mol. Cell. Biochem. 1996; 157: 259-67.
16. Iwanaga Y, Kihara Y, Hasewaga K et al. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 1998; 98: 2065-73.
17. Oie E, Bjonerheim R, Grogaard HK, Kongshaug H, Smiseth OA, Attramadal H. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats. Am. J. Physiol. 1998; 275: H868-77.
18. A receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats. Hypertension 1999; 33: 954-60.
19. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994; 89: 2198-203.
20. Fareh J, Touyz RM, Schiffrin EL, Thibault G. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Circ. Res. 1996; 78: 302-11.
21. 1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: Involvement of endothelin. Eur. J. Pharmacol. 1995; 280: 11-17.
22. Herizi A, Jover B, Bouriquet N, Mimran A. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade. Hypertension 1998; 31: 10-14.
23. Zhang Y, Oliver JR, Horowitz JD. Endothelin B receptor mediated vasoconstriction induced by endothelin A receptor antagonist. Cardiovasc. Res. 1998; 39: 665-73.
24. Hirata Y, Emori T, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediated synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest. 1993; 91: 1367-73.
25. B receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 1993; 194: 1282-7.
26. Arai M, Yoguchi A, Iso T et al. Endothelin-1 and its binding sites are upregualted in pressure overload cardiac hypertrophy. Am. J. Physiol. 1995; 268: H2084-91.
27. Barton M, Shaw S, d'Uscio LV, Moreau P, Luscher TF. Differential modulation of the renal and myocardial endothelin system by angiotensin II in vivo. J. Cardiovasc. Pharmacol. 1998; 31 (Suppl. 1): S265-8.
28. 2+] in the neonatal rat cardiomyocyte. Circ. Res. 1991; 69: 239-45.
29. Xu Y, Hopfner RL, McNeill JR, Gopalakrishnan V. Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 1999; 195: 183-90.
30. 1A receptor. Eur. J. Pharmacol. 2000; 391: 39-48.
31. 1 receptor. Mol. Cell. Biochem. 1999; 195: 93-8.
32. Burrell LM, Phillips PA, Risvanis J, Aldred KL, Johnston CI. Beneficial effects of vasopressin V2/V1 receptor blockade in myocardial infarction. J. Hypertens. 1996; 14 (Suppl. 1): S158 (Abstract).
33. Emori T, Hirata Y, Ohta K et al. Cellular mechanism and endothelin-1 release by angiotensin and vasopressin. Hypertension 1991; 18: 165-70.
34. Wagner OF, Christ G, Wojta J et al. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 1992; 267: 16 066-8.